|
66 |
A guide to risk assessments for cleanroom containment
|
sureAssist |
2024-12-26 |
143 |
|
65 |
WHO issues guidance on nitrosamine controls in drug manufacturing
|
sureAssist |
2024-12-26 |
132 |
|
64 |
Key Considerations For Emerging Companies When Selecting Packaging Components
|
sureAssist |
2024-12-26 |
136 |
|
63 |
FDA proposes rule for difficult-to-compound drugs, drug categories
|
sureAssist |
2024-12-26 |
135 |
|
62 |
Should you automate your processes in pharmaceutical sterilisation?
|
sureAssist |
2024-12-26 |
143 |
|
61 |
Navigating the complexities of cleanrooms and sterile spaces
|
sureAssist |
2024-12-26 |
135 |
|
60 |
How well does technology safeguard pharmaceutical purified water from microorganisms?
|
sureAssist |
2024-12-26 |
140 |
|
59 |
Master Protocols for Drug and Biological Product Development
|
sureAssist |
2024-12-26 |
146 |
|
58 |
Where to find GDP Certificates and Wholesale Distributor Authorizations
|
sureAssist |
2024-12-26 |
139 |
|
57 |
Single-use technology propelling upstream bioprocessing market expansion
|
sureAssist |
2024-12-26 |
169 |
